Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Hum Psychopharmacol. 2009 Oct;24(7):584–589. doi: 10.1002/hup.1056

Table 2.

Summary of current treatment data for subjects who received clozapine and lithium carbonate.

Subject number Nadir neutrophil count on first exposure (×103/μL) Duration of first neutropenia (days) Range of stable dosage of Clozapine (mg/day) Range of dosage of Lithium Carbonate used in Clozapine escalation (mg/day) Duration between initiation of Lithium and initiation of Clozapine (days) Median ANC before initiation of Lithium Median ANC after initiation of Lithium p value# Current Lithium Carbonate dosage (mg/day) Duration of Lithium Carbonate Use (years)
1 1.05 54 350-400 450-900 7 1.76 2.77 7.3×10-6 N/A 0.2
2 0.95 5 350 900 0 1.46 2.75 0.00025 900 (450 bid) 2.5
3 1.26 3 150-450 825-1350 84 1.97 2.06 0.14 500 (250 bid) 7.2
4 1.12 58 300-400 900-1500 N/A 1.59 2.05 0.00053 N/A 6.2
5 1.44 14 400 600-1500 N/A 1.77 3.64 0.0027 N/A 3.3
6 1.41 27 350 600 -18 2.02 3.64 0.00019 700 (350 bid) 2.4
7 1.54 13 175-500 1050-1500 6 1.54 2.11 0.0022 1650 (900+750) 2.0
#

Student t-test comparing ANC values before and after lithium carbonate initiation ANC = Absolute neutrophil count